These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

954 related articles for article (PubMed ID: 21747054)

  • 21. Transapical transcatheter treatment of a stenosed aortic valve bioprosthesis using the Edwards SAPIEN Transcatheter Heart Valve.
    Klaaborg KE; Egeblad H; Jakobsen CJ; Terp K; Lindskov C; Andersen HR; Thuesen L
    Ann Thorac Surg; 2009 Jun; 87(6):1943-6. PubMed ID: 19463633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcatheter aortic valve implantation in patients with very high risk for conventional aortic valve replacement.
    Thielmann M; Wendt D; Eggebrecht H; Kahlert P; Massoudy P; Kamler M; Erbel R; Jakob H; Sack S
    Ann Thorac Surg; 2009 Nov; 88(5):1468-74. PubMed ID: 19853095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immediate and 6-month outcomes of transapical and transfemoral Edwards-Sapien prosthesis implantation in patients with aortic stenosis.
    Chodór P; Wilczek K; Przybylski R; Krasoń M; Głowacki J; Niklewski T; Podolecki T; Kalarus Z; Poloński L; Zembala M
    Kardiol Pol; 2010 Oct; 68(10):1124-31. PubMed ID: 20967708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and hemodynamic outcomes of "all-comers" undergoing transapical aortic valve implantation: results from the Italian Registry of Trans-Apical Aortic Valve Implantation (I-TA).
    D'Onofrio A; Rubino P; Fusari M; Salvador L; Musumeci F; Rinaldi M; Vitali EO; Glauber M; Di Bartolomeo R; Alfieri OR; Polesel E; Aiello M; Casabona R; Livi U; Grossi C; Cassese M; Pappalardo A; Gherli T; Stefanelli G; Faggian GG; Gerosa G
    J Thorac Cardiovasc Surg; 2011 Oct; 142(4):768-75. PubMed ID: 21840020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcatheter valve-in-valve implantation for deteriorated aortic bioprosthesis: initial clinical results and follow-up in a series of high-risk patients.
    Wilbring M; Sill B; Tugtekin SM; Alexiou K; Simonis G; Matschke K; Kappert U
    Ann Thorac Surg; 2012 Mar; 93(3):734-41. PubMed ID: 22304904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.
    Fearon WF; Kodali S; Doshi D; Fischbein MP; Yeung AC; Tuzcu EM; Rihal CS; Babaliaros V; Zajarias A; Herrmann HC; Brown DL; Mack M; Teirstein PS; Whisenant BK; Makkar R; Kapadia S; Leon MB;
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1245-51. PubMed ID: 25459036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immediate and mid-term results of transfemoral aortic valve implantation using either the Edwards Sapien transcatheter heart valve or the Medtronic CoreValve System in high-risk patients with aortic stenosis.
    Attias D; Himbert D; Ducrocq G; Détaint D; Al-Attar N; Iung B; Francis F; Maury JM; Brochet E; Enguerrand D; Nataf P; Vahanian A
    Arch Cardiovasc Dis; 2010 Apr; 103(4):236-45. PubMed ID: 20656634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transapical versus transfemoral aortic valve implantation: a comparison of survival and safety.
    Johansson M; Nozohoor S; Kimblad PO; Harnek J; Olivecrona GK; Sjögren J
    Ann Thorac Surg; 2011 Jan; 91(1):57-63. PubMed ID: 21172486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Causes of peri-operative mortality after transcatheter aortic valve implantation: a pooled analysis of 12 studies and 1223 patients.
    Moreno R; Calvo L; Salinas P; Dobarro D; Santiago JV; Sanchez-Recalde A; Galeote G; Riera L; Moreno-Gomez I; Mesa J; Plaza I; Lopez-Sendon J
    J Invasive Cardiol; 2011 May; 23(5):180-4. PubMed ID: 21562344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration).
    Chieffo A; Buchanan GL; Van Mieghem NM; Tchetche D; Dumonteil N; Latib A; van der Boon RM; Vahdat O; Marcheix B; Farah B; Serruys PW; Fajadet J; Carrié D; de Jaegere PP; Colombo A
    J Am Coll Cardiol; 2013 Feb; 61(8):830-6. PubMed ID: 23333140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [POL-TAVI First--Polish report on transcatheter aortic valve implantation (TAVI) of Edwards-Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities].
    Zembala M; Wilczek K; Przybylski R; Chodór P; Nadziakiewicz P; Krasoń M; Sadowski J; Dudek D; Kapelak B; Forysz D; Witkowski A; Demkow M; Chmielak Z; Kuśmierski K; Juraszyński Z; Bochenek A; Cisowski M; Trusz-Gluza M; Buszman P; Woś S; Kalarus Z; Poloński L; Gasior M; Opolski G; Ruzyłło W
    Kardiol Pol; 2009 Aug; 67(8):936-40. PubMed ID: 19784896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single center experience with transcatheter aortic valve implantation using the Edwards SAPIEN™ Valve.
    Nielsen HH; Thuesen L; Egeblad H; Poulsen SH; Klaaborg KE; Jakobsen CJ; Andersen HR; Hjortdal VE
    Scand Cardiovasc J; 2011 Oct; 45(5):261-6. PubMed ID: 21506661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
    Godino C; Maisano F; Montorfano M; Latib A; Chieffo A; Michev I; Al-Lamee R; Bande M; Mussardo M; Arioli F; Ielasi A; Cioni M; Taramasso M; Arendar I; Grimaldi A; Spagnolo P; Zangrillo A; La Canna G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1110-21. PubMed ID: 21087745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry.
    Dvir D; Webb J; Brecker S; Bleiziffer S; Hildick-Smith D; Colombo A; Descoutures F; Hengstenberg C; Moat NE; Bekeredjian R; Napodano M; Testa L; Lefevre T; Guetta V; Nissen H; Hernández JM; Roy D; Teles RC; Segev A; Dumonteil N; Fiorina C; Gotzmann M; Tchetche D; Abdel-Wahab M; De Marco F; Baumbach A; Laborde JC; Kornowski R
    Circulation; 2012 Nov; 126(19):2335-44. PubMed ID: 23052028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival, predictive factors, and causes of mortality following transcatheter aortic valve implantation.
    Alassar A; Roy D; Valencia O; Brecker S; Jahangiri M
    Innovations (Phila); 2013; 8(5):359-63. PubMed ID: 24346585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
    Eltchaninoff H; Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A
    Arch Cardiovasc Dis; 2012 Mar; 105(3):132-40. PubMed ID: 22520795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis.
    Ussia GP; Barbanti M; Petronio AS; Tarantini G; Ettori F; Colombo A; Violini R; Ramondo A; Santoro G; Klugmann S; Bedogni F; Maisano F; Marzocchi A; Poli A; De Carlo M; Napodano M; Fiorina C; De Marco F; Antoniucci D; de Cillis E; Capodanno D; Tamburino C;
    Eur Heart J; 2012 Apr; 33(8):969-76. PubMed ID: 22240494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN™ and Medtronic CoreValve ReValving System® devices: the Milan registry.
    Buchanan GL; Chieffo A; Montorfano M; Maisano F; Latib A; Godino C; Cioni M; Gullace MA; Franco A; Gerli C; Alfieri O; Colombo A
    EuroIntervention; 2011 Sep; 7(5):556-63. PubMed ID: 21930459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Commercial versus PARTNER study experience with the transfemoral Edwards SAPIEN valve for inoperable patients with severe aortic stenosis.
    Pendyala LK; Minha S; Barbash IM; Torguson R; Magalhaes MA; Okubagzi P; Loh JP; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jan; 113(2):342-7. PubMed ID: 24220281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PREVAIL TRANSAPICAL: multicentre trial of transcatheter aortic valve implantation using the newly designed bioprosthesis (SAPIEN-XT) and delivery system (ASCENDRA-II).
    Walther T; Thielmann M; Kempfert J; Schroefel H; Wimmer-Greinecker G; Treede H; Wahlers T; Wendler O
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):278-83; discussion 283. PubMed ID: 22293620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.